Published: 5 May 2022
Author(s): Cas J. Isfordink, Marleen van Dijk, Sylvia M. Brakenhoff, Patricia A.M. Kracht, Joop E. Arends, Robert J. de Knegt, Marc van der Valk, Joost P.H. Drenth, on behalf of CELINE Study Group
Issue: June 2022
Section: Original article

Achieving hepatitis C virus (HCV) elimination as a global health threat has been a priority of many countries since the World Health Organisation published their elimination targets [1]. In low-endemic countries, like the Netherlands (prevalence 0.16%) [2], micro-elimination may be a favourable approach [3].

Newsletters

Stay informed on our latest news!